Cambridge Investment Research Advisors
TNDM icon

Cambridge Investment Research Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$789K Buy
+52,295
New +$913K ﹤0.01% 2336
2025
Q1 		– Sell
-23,953
Closed -$863K – 3635
2024
Q4 		$863K Buy
23,953
+10,286
+75% +$348K ﹤0.01% 1987
2024
Q3 		$580K Buy
13,667
+679
+5% +$28.8K ﹤0.01% 2289
2024
Q2 		$523K Sell
12,988
-300
-2% -$12.5K ﹤0.01% 2264
2024
Q1 		$471K Buy
+13,288
New +$356K ﹤0.01% 2328
2023
Q2 		– Sell
-6,388
Closed -$259K – 3290
2023
Q1 		$259K Buy
6,388
+160
+3% +$6.62K ﹤0.01% 2609
2022
Q4 		$280K Buy
6,228
+49
+0.8% +$2.22K ﹤0.01% 2485
2022
Q3 		$296K Buy
6,179
+300
+5% +$16.4K ﹤0.01% 2370
2022
Q2 		$348K Sell
5,879
-640
-10% -$52.5K ﹤0.01% 2246
2022
Q1 		$758K Sell
6,519
-500
-7% -$58.4K ﹤0.01% 1787
2021
Q4 		$1.06M Buy
7,019
+55
+0.8% +$7.42K ﹤0.01% 1545
2021
Q3 		$831K Sell
6,964
-200
-3% -$22K ﹤0.01% 1677
2021
Q2 		$698K Sell
7,164
-727
-9% -$64.8K ﹤0.01% 1797
2021
Q1 		$696K Buy
7,891
+331
+4% +$30.8K ﹤0.01% 1663
2020
Q4 		$723K Buy
7,560
+4,248
+128% +$438K ﹤0.01% 1521
2020
Q3 		$376K Buy
3,312
+331
+11% +$34.8K ﹤0.01% 1783
2020
Q2 		$295K Buy
+2,981
New +$238K ﹤0.01% 1899
2019
Q4 		– Sell
-10,181
Closed -$600K – 2474
2019
Q3 		$600K Buy
10,181
+151
+2% +$9.64K 0.01% 1379
2019
Q2 		$647K Sell
10,030
-2,538
-20% -$164K 0.01% 1275
2019
Q1 		$798K Buy
+12,568
New +$660K 0.01% 1168
2018
Q4 		– Sell
-10,260
Closed -$440K – 2282
2018
Q3 		$440K Buy
+10,260
New +$358K ﹤0.01% 1526

Other funds holding TNDM

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Cambridge Investment Research Advisors's TNDM Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 52,295 shares worth $789K. The stake represents ﹤0.01% of the portfolio and ranks #2336 among its holdings. This is a return to the name: Cambridge Investment Research Advisors previously reported a position in TNDM as recently as Q4 2024.

Cambridge Investment Research Advisors first reported a position in TNDM in Q3 2018 and has held it in 21 quarters since. The position peaked at $1.06M in Q4 2021. 57 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Cambridge Investment Research Advisors held 52,295 shares of Tandem Diabetes Care worth $789K as of Q2 2026.
  • Tandem Diabetes Care was a new Cambridge Investment Research Advisors position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2336 holding.
  • Cambridge Investment Research Advisors first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 21 quarters since.
  • Cambridge Investment Research Advisors's Tandem Diabetes Care position peaked at $1.06M in Q4 2021.
  • 57 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.